{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:01:11Z","timestamp":1787162471481,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770724"],"award-info":[{"award-number":["81770724"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.prp.2025.156286","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T15:45:16Z","timestamp":1762703116000},"page":"156286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["CSB6B attenuates renal inflammation and fibrosis by inhibiting the activation of NLRP3 inflammasome through the NLRP3\/Caspase-1\/GSDMD\/IL-1\u03b2 signaling pathway"],"prefix":"10.1016","volume":"277","author":[{"given":"Shuo","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuling","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.prp.2025.156286_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","article-title":"Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors","volume":"17","author":"DeFronzo","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.prp.2025.156286_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114252","article-title":"Diabetic nephropathy: Focusing on pathological signals, clinical treatment, and dietary regulation","volume":"159","author":"Hu","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"4","key":"10.1016\/j.prp.2025.156286_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","article-title":"The NLRP3 inflammasome: activation and regulation","volume":"48","author":"Xu","year":"2023","journal-title":"Trends Biochem Sci."},{"issue":"2","key":"10.1016\/j.prp.2025.156286_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10565-019-09496-2","article-title":"Cell death mechanisms in eukaryotes","volume":"36","author":"Nirmala","year":"2020","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.prp.2025.156286_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108024","article-title":"Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies","volume":"233","author":"Sumaiya","year":"2022","journal-title":"Pharm. Ther."},{"issue":"9","key":"10.1016\/j.prp.2025.156286_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23094908","article-title":"Macrophage migration inhibitory factor (MIF) as a stress molecule in renal inflammation","volume":"23","author":"Kong","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.prp.2025.156286_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00008","article-title":"Macrophage migration inhibitory factor in clinical kidney disease","volume":"7","author":"Bruchfeld","year":"2016","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.prp.2025.156286_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/14728222.2019.1656718","article-title":"Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus","volume":"23","author":"Bilsborrow","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"issue":"7","key":"10.1016\/j.prp.2025.156286_bib9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/thorax-2021-218555","article-title":"Macrophage migration inhibitory factor promotes glucocorticoid resistance of neutrophilic inflammation in a murine model of severe asthma","volume":"78","author":"Allam","year":"2023","journal-title":"Thorax"},{"key":"10.1016\/j.prp.2025.156286_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120949","article-title":"Rhodiola activates macrophage migration inhibitory factor to alleviate non-alcoholic fatty liver disease","volume":"308","author":"Liu","year":"2022","journal-title":"Life Sci."},{"issue":"9","key":"10.1016\/j.prp.2025.156286_bib11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11926-022-01081-7","article-title":"Deep insight into the role of MIF in Spondyloarthritis","volume":"24","author":"Wu","year":"2022","journal-title":"Curr. Rheuma Rep."},{"issue":"2","key":"10.1016\/j.prp.2025.156286_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41419-021-03426-z","article-title":"Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer","volume":"12","author":"Klemke","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.prp.2025.156286_bib13","doi-asserted-by":"crossref","first-page":"L6","DOI":"10.1152\/ajplung.00288.2020","article-title":"Inhibition of macrophage migration inhibitory factor (MIF) as a therapeutic target in bleomycin-induced pulmonary fibrosis rats","volume":"321","author":"Luo","year":"2021","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"3","key":"10.1016\/j.prp.2025.156286_bib14","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3233\/JAD-215561","article-title":"Early prediction of a pre-symptomatic neurodegeneration disorder by measuring macrophage inhibitory factor level in diabetic patients","volume":"88","author":"Khalil","year":"2022","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.prp.2025.156286_bib15","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.3389\/fimmu.2019.02752","article-title":"The proinflammatory and proangiogenic macrophage migration inhibitory factor is a potential regulator in proliferative diabetic retinopathy","volume":"10","author":"Abu El-Asrar","year":"2019","journal-title":"Front Immunol."},{"issue":"3","key":"10.1016\/j.prp.2025.156286_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.5603\/EP.a2018.0028","article-title":"MIF\/CD74 axis is a target for metformin therapy in diabetic podocytopathy - real world evidence","volume":"69","author":"Xing","year":"2018","journal-title":"Endokrynol. Pol."},{"issue":"2","key":"10.1016\/j.prp.2025.156286_bib17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1681\/ASN.2008020194","article-title":"The MIF receptor CD74 in diabetic podocyte injury","volume":"20","author":"Sanchez-Nino","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.prp.2025.156286_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105396","article-title":"HDAC\/MIF dual inhibitor inhibits NSCLC cell survival and proliferation by blocking the AKT pathway","volume":"117","author":"Cao","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.prp.2025.156286_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117280","article-title":"Progress in the development of Macrophage Migration Inhibitory Factor small-molecule inhibitors","volume":"286","author":"Guo","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.prp.2025.156286_bib20","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1681\/ASN.2021030294","article-title":"Reduced glomerular filtration in diabetes is attributable to loss of density and increased resistance of glomerular endothelial cell fenestrations","volume":"33","author":"Finch","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.prp.2025.156286_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0217-3","article-title":"Lysophosphatidic acid increases mesangial cell proliferation in models of diabetic nephropathy via Rac1\/MAPK\/KLF5 signaling","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.prp.2025.156286_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00592-018-1128-9","article-title":"The relationship between the thickness of glomerular basement membrane and renal outcomes in patients with diabetic nephropathy","volume":"55","author":"Zhang","year":"2018","journal-title":"Acta Diabetol."},{"issue":"6","key":"10.1016\/j.prp.2025.156286_bib23","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2337\/dc15-0184","article-title":"Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes","volume":"38","author":"Krolewski","year":"2015","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.prp.2025.156286_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ph15121494","article-title":"Renal proximal tubular cells: a new site for targeted delivery therapy of diabetic kidney disease","volume":"15","author":"Li","year":"2022","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.prp.2025.156286_bib25","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00467-004-1494-0","article-title":"Protein reabsorption in renal proximal tubule-function and dysfunction in kidney pathophysiology","volume":"19","author":"Christensen","year":"2004","journal-title":"Pedia Nephrol."},{"issue":"33","key":"10.1016\/j.prp.2025.156286_bib26","doi-asserted-by":"crossref","first-page":"34302","DOI":"10.1074\/jbc.M405608200","article-title":"Linking receptor-mediated endocytosis and cell signaling: evidence for regulated intramembrane proteolysis of megalin in proximal tubule","volume":"279","author":"Zou","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.prp.2025.156286_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.prp.2025.156286_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3596","article-title":"Role of renal tubular programed cell death in diabetic kidney disease","volume":"39","author":"Zhou","year":"2023","journal-title":"Diabetes Metab. Res Rev."},{"issue":"7575","key":"10.1016\/j.prp.2025.156286_bib29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.prp.2025.156286_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","article-title":"The immunobiology of MIF: function, genetics and prospects for precision medicine","volume":"15","author":"Kang","year":"2019","journal-title":"Nat. Rev. Rheuma"},{"issue":"1","key":"10.1016\/j.prp.2025.156286_bib31","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1038\/s41467-018-04581-2","article-title":"Macrophage migration inhibitory factor is required for NLRP3 inflammasome activation","volume":"9","author":"Lang","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.prp.2025.156286_bib32","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.40672","article-title":"Macrophage migration inhibitory factor regulates U1 small nuclear RNP immune complex-mediated activation of the NLRP3 inflammasome","volume":"71","author":"Shin","year":"2019","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.prp.2025.156286_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106263","article-title":"CSB6B prevents \u03b2-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-\u03baB and NLRP3 in microglia cells","volume":"81","author":"Yan","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.prp.2025.156286_bib34","article-title":"Chicago sky blue 6B exerts neuroprotective and anti-inflammatory effects on focal cerebral ischemia","volume":"170","author":"Pomierny","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"10","key":"10.1016\/j.prp.2025.156286_bib35","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1021\/acsmedchemlett.9b00351","article-title":"Inhibition of macrophage migration inhibitory factor by a chimera of two allosteric binders","volume":"11","author":"Cirillo","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.prp.2025.156286_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106263","article-title":"CSB6B prevents beta-amyloid-associated neuroinflammation and cognitive impairments via inhibiting NF-kappaB and NLRP3 in microglia cells","volume":"81","author":"Yan","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"45","key":"10.1016\/j.prp.2025.156286_bib37","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2111643118","article-title":"Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease","volume":"118","author":"Ahuja","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.prp.2025.156286_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1404","article-title":"Inflammasome activation: from molecular mechanisms to autoinflammation","volume":"11","author":"Lara-Reyna","year":"2022","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.prp.2025.156286_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114734","article-title":"Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-kappaB signaling pathway","volume":"192","author":"Jin","year":"2021","journal-title":"Biochem. Pharm."},{"issue":"16","key":"10.1016\/j.prp.2025.156286_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168780","article-title":"NLRP3 Ubiquitination-a new approach to target NLRP3 inflammasome activation","volume":"22","author":"Akther","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2025.156286_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bbrc.2016.09.010","article-title":"An ubiquitin-binding molecule can work as an inhibitor of ubiquitin processing enzymes and ubiquitin receptors","volume":"479","author":"Nguyen","year":"2016","journal-title":"Biochem Biophys. Res Commun."},{"issue":"5","key":"10.1016\/j.prp.2025.156286_bib42","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.3390\/ijms18051083","article-title":"SGLT2 inhibitors as a therapeutic option for diabetic nephropathy","volume":"18","author":"Kawanami","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"ement_2","key":"10.1016\/j.prp.2025.156286_bib43","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.2337\/dcS15-3006","article-title":"SGLT2 inhibitors and the diabetic kidney","volume":"39","author":"Fioretto","year":"2016","journal-title":"Diabetes Care"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033825004790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:11:22Z","timestamp":1766067082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033825004790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":43,"alternative-id":["S0344033825004790"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.156286","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSB6B attenuates renal inflammation and fibrosis by inhibiting the activation of NLRP3 inflammasome through the NLRP3\/Caspase-1\/GSDMD\/IL-1\u03b2 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.156286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156286"}}